Alberto-Culver management
This article was originally published in The Rose Sheet
Executive Summary
Firm appoints Ralph J. Nicoletti as senior VP and chief financial officer, announced March 1. The exec previously spent 27 years at Kraft Foods, where he served as VP-corporate audit and, before that, as senior VP-finance for Kraft Foods North America. In addition to personal care products such as Alberto VO5 and St. Ives, Alberto-Culver also markets household products such as Mrs. Dash and Static Guard. Nicoletti's appointment is "an important part of our restructuring as a focused consumer products company," Alberto-Culver President and CEO V. James Marino said. The firm reported financial results for its first quarter of independence in January, after splitting from Sally Beauty in November 2006 (1"The Rose Sheet" Jan. 29, 2007, In Brief)...
You may also be interested in...
Alberto-Culver Q1
Firm reports results of its first quarter (ended Dec. 31) as an independent company Jan. 25, crediting 12.6% increase in sales to $351.1 mil. to strong growth in Nexxus and TRESemme. Gross profit grew 12.3% to $180.9 mil., while earnings were "essentially breakeven" after restructuring costs, firm says. The company increased its ad spend 20.9% to $61 mil. as part of an "ongoing effort to support and further expand our brands," president and CEO V. James Marino said. "This quarter marks a new beginning for Alberto-Culver and its shareholders, and we are focused on our efforts to drive results and create value over the long term," he remarked. Brand announced a "right-sizing" plan in December (1"The Rose Sheet" Dec. 4, 2006, In Brief)...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.